Table 2

Overview of data collection from consented deceased organ donors

Data typeData capture includes
Monitoring devicesArterial catheter
Central venous catheter
Pulmonary artery catheter
Echocardiography
Advanced organ-sustaining therapiesMechanical ventilation
Vasopressors and inotropes
Cardiopulmonary resuscitation
Renal replacement therapy
Fluid resuscitation
Enteral/parenteral nutrition
Prophylactic medicationsGastrointestinal prophylaxis
Thromboprophylaxis
Pneumonia prophylaxis
Glycaemic control
Donation-specific therapiesGlucocorticosteroids
Thyroid hormone
Vasopressin infusions
DDAVP administration
Therapeutic heparin
Antimicrobial therapy
Potentially adverse ICU exposuresOxygen desaturation (SpO2 <88% for ≥15 min)
Haemodynamic instability (mean arterial pressure <65 mm Hg for ≥15 min or new vasopressors initiated for treatment of hypotension)
Cardiac arrhythmias requiring chemical or electrical cardioversion
Active bleeding requiring blood transfusion
Extremes of body temperature (<36°C or >38.5°C)
Neurological death declarationTime of death
Details related to
apnoea test
Ancillary tests
Cardiocirculatory death declarationSequence of advanced organ-sustaining therapy withdrawal
Changes in dose of palliative medications
Evolution of vital signs after withdrawal of organ-sustaining therapy
Organ suitability assessmentsBlood tests
Chest radiography
Bronchoscopy
Body imaging
Echocardiography
Coronary angiography
Microbiological cultures
Biopsies
Time and rationale for organ decline
Transplant recipientsAge
Sex
Panel reactive antigen
Transplant programme
Transplant date
  • ICU, intensive care unit.